Pfizer (PFE) Total Liabilities (2009 - 2026)

Pfizer (PFE) has 18 years of Total Liabilities data on file, last reported at $117.2 billion in Q1 2026.

• Total Liabilities for Q1 2026 came in at $117.2 billion, changed 0.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $117.2 billion (changed 0.15% YoY), and the FY2025 annual result was $121.4 billion, down 2.81% from the prior year.
• Total Liabilities slipped to $117.2 billion in Q1 2026 per PFE's latest filing, from $121.4 billion in the prior quarter.
• Over five years, Total Liabilities peaked at $137.2 billion in Q4 2023 and troughed at $22.5 billion in Q4 2022.
• A 5-year average of $111.8 billion and a median of $117.4 billion in 2025 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2023 and 2024: Total Liabilities soared 424.68% in 2023, then fell 8.97% in 2024.
• A 5-year view of Total Liabilities shows it stood at $101.3 billion in 2022, then surged by 35.47% to $137.2 billion in 2023, then slipped by 8.97% to $124.9 billion in 2024, then declined by 2.81% to $121.4 billion in 2025, then slipped by 3.44% to $117.2 billion in 2026.
• Business Quant data shows PFE's Total Liabilities at $117.2 billion in Q1 2026, $121.4 billion in Q4 2025, and $115.6 billion in Q3 2025.